Digital transformation is commonly seen as a means for pharmaceutical companies to reduce innovation cycles and fundamentally reimagine the value chain. One key element that holds back many life sciences companies is their struggle to deal with the heterogeneous and ambiguous nature of their data.
In this report, Eliot Randle, Managing Partner & Co-Founder of Digital Lab Consulting considers data strategies to underpin digital transformation.
Digital technologies have the potential to transform businesses across all industry sectors, but most life sciences companies have not yet made the bolder moves other sectors have in taking advantage of their capabilities.
Joanne Henderson, Executive Director; Head of Life Sciences, EMEA at CBRE explores the Digital Talent Challenge and how real estate and workplace strategies can help.
We are delighted to report on a recent discussion on the technology that will drive the Lab of the Future; with Cindy Novak-DeLaurell from Takeda, Beeta Balali-Mood, Lab of the Future Lead at Pistoia Alliance, Martin Winter of Lab Automation Network and Gerhard Noelken also of Pistoia Alliance.